FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

9539111000001109: Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31113301000001118 Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
95795301000001116 Boots Mucus Cough Relief 100mg/5ml oral solution (The Boots Company Plc) 150 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Is a Guaifenesin 100mg/5ml oral solution 150 ml true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Is pack of Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) false Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has active ingredient Guaifenesin false Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Legal category General sales list true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has AMP Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has specific active ingredient Guaifenesin true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Nirolex Chesty Cough 100mg/5ml linctus (The Boots Company) 150 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start